Return to Article Details IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC/ ESBL PRODUCING ENTEROBACTERIACEAE Download Download PDF